Newsbenzinga
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness
· Published
Article summary
FDA names seven companies to its PreCheck pilot to speed U.S. drug manufacturing reviews after receiving more than 80 applications.
An excerpt from the original article.
Comments —
Loading comments…